Regulation of Elongation Factor-1α Expression by Growth Factors and Anti-receptor Blocking Antibodies

This publication has 42 references indexed in Scilit:

• Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
  Journal of Clinical Oncology, 2000
• Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
  Journal of Clinical Oncology, 1999
• A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
  Cell, 1994
• Elongation factor-1 messenger-RNA levels in cultured cells are high compared to tissue and are not drastically affected further by oncogenic transformation
  Nucleic Acids Research, 1992
• Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells.
  Molecular and Cellular Biology, 1991
• Compartmentalization and actin binding properties of ABP‐50: The elongation factor‐1 alpha of Dictyostelium
  Cell Motility, 1991
• Eukaryotic protein elongation factors
  Trends in Biochemical Sciences, 1990
• Signal transduction by receptors with tyrosine kinase activity
  Published by Elsevier ,1990
• p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
  Molecular and Cellular Biology, 1989
• Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.
  Proceedings of the National Academy of Sciences, 1983